These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27187166)

  • 1. MRI of Prostate Cancer: Update.
    Verma S
    Top Magn Reson Imaging; 2016 Jun; 25(3):101. PubMed ID: 27187166
    [No Abstract]   [Full Text] [Related]  

  • 2. MR-TRUS Fusion Biopsy.
    Margolis DJ
    Top Magn Reson Imaging; 2016 Jun; 25(3):125-31. PubMed ID: 27187163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer.
    Bittencourt LK; de Hollanda ES; de Oliveira RV
    Top Magn Reson Imaging; 2016 Jun; 25(3):109-17. PubMed ID: 27187165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of prostate cancer].
    Roosen A
    MMW Fortschr Med; 2014 Dec; 156(21-22):67-70. PubMed ID: 25608414
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Perspective of Prostate Cancer.
    Patil N; Gaitonde K
    Top Magn Reson Imaging; 2016 Jun; 25(3):103-8. PubMed ID: 27187167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
    Durmus T; Baur A; Hamm B
    Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy.
    Verma S; Rosenkrantz AB; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    Abdom Radiol (NY); 2017 Feb; 42(2):346-349. PubMed ID: 27670878
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Klingebiel M; Ullrich T; Rabenalt R; Albers P; Antoch G; Schimmöller L
    Rofo; 2018 Nov; 190(11):1067-1069. PubMed ID: 29874701
    [No Abstract]   [Full Text] [Related]  

  • 9. Prebiopsy magnetic resonance studies for prostate cancer diagnosis.
    Kumar R; Jagannathan NR
    Int J Urol; 2013 Feb; 20(2):140-1. PubMed ID: 23088316
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate imaging reporting and data system (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI.
    Westphalen AC; Rosenkrantz AB
    AJR Am J Roentgenol; 2014 Jan; 202(1):121-3. PubMed ID: 24370136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
    Yoo S; Kim JK; Jeong IG
    Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.
    Abdi H; Zargar H; Goldenberg SL; Walshe T; Pourmalek F; Eddy C; Chang SD; Gleave ME; Harris AC; So AI; Machan L; Black PC
    Urol Oncol; 2015 Apr; 33(4):165.e1-7. PubMed ID: 25665509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Siegel C
    J Urol; 2013 Sep; 190(3):881. PubMed ID: 23931195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
    Franiel T
    Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
    Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
    IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
    Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
    Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted biopsy with MRI and ultrasound improves detection of high risk prostate cancer.
    Mayor S
    BMJ; 2015 Jan; 350():h472. PubMed ID: 25630373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging-guided prostate biopsy techniques.
    Verma S; Bhavsar AS; Donovan J
    Magn Reson Imaging Clin N Am; 2014 May; 22(2):135-44, v. PubMed ID: 24792674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.